In last trading session, Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) saw 0.44 million shares changing hands with its beta currently measuring -0.44. Company’s recent per share price level of $229.84 trading at $13.79 or 6.38% at ring of the bell on the day assigns it a market valuation of $4.82B. That closing price of MDGL’s stock is at a discount of -36.23% from its 52-week high price of $313.11 and is indicating a premium of 47.89% from its 52-week low price of $119.76. Taking a look at company’s average trading volume volume of 612.84K if we extend that period to 3-months.
Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) trade information
Upright in the green during last session for gaining 6.38%, in the last five days MDGL remained trading in the green while hitting it’s week-highest on Friday, 05/03/24 when the stock touched $229.84 price level, adding 1.97% to its value on the day. Madrigal Pharmaceuticals Inc’s shares saw a change of -0.67% in year-to-date performance and have moved 18.88% in past 5-day. Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) showed a performance of -4.81% in past 30-days.
Madrigal Pharmaceuticals Inc (MDGL) estimates and forecasts
Statistics highlight that Madrigal Pharmaceuticals Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 68.39% of value to its shares in past 6 months, showing an annual growth rate of -9.35% while that of industry is 11.50. Apart from that, the company came lowering its revenue forecast for fiscal year 2024.
And 12 analysts are in estimates of company making revenue of 4.3M in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -55.24% during past 5 years. In 2024, company’s earnings growth rate is likely to be around -16.87% while estimates for its earnings growth in next 5 years are of 0.00%.
MDGL Dividends
Madrigal Pharmaceuticals Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
